Regeneron and Sanofi Immuno-Oncology deal
Posted on29 Jul 2015
Tagscodevelopment deal in pharma, Immuno-Oncology deal, Regeneron, Regeneron and Sanofi Immuno-Oncology deal, Sanofi
Comments0
Regeneron Pharmaceuticals, Inc. and Sanofi have entered into a new global collaboration to discover, develop and commercialize new antibody cancer treatments in... Read More
Hikma to buy Boehringer’s U.S. generics unit for $2.65 billion
Posted on28 Jul 2015
Comments0
Hikma Pharmaceuticals Plc said it would buy German drugmaker Boehringer Ingelheim’s U.S. specialty generic drugs (Roxane) business for about $2.65 billion. Hikma’s new... Read More
Teva to acquire Allergan Generics for $40.5 Bn
Teva Pharmaceutical Industries Ltd. agreed to buy Allergan PLC’s generics unit for $40.5 billion in cash and stock, in a deal that... Read More
What is the meaning of me-too or follow on drugs?
Me-too drugs and Follow on drugs are the common terminologies which used by pharmaceutical marketer. A compound that is structurally very similar... Read More
Janssen submits sNDA to US FDA for once-daily Olysio in combo with sofosbuvir
Posted on26 Jul 2015
Comments0
Janssen Therapeutics, Division of Janssen Products, LP (Janssen), has submitted a supplemental New Drug Application (sNDA) to the US Food and Drug... Read More
Biocon’s first time ophthalmology molecule, QPI-1007, entered in clinical trial
Biocon’s novel drug pipeline which has an ophthalmology molecule, QPI-1007, is entering clinical trial phase. QPI-1007 is for ocular neuroprotection in NAION... Read More
What is meaning of “compassionate use” in drug regulatory affairs?
Expanded access, sometimes called “compassionate use,” is the use of an investigational drug outside of a clinical trial to treat a patient... Read More
Perrigo to acquire Naturwohl Pharma and its leading German dietary supplement brand, Yokebe
Posted on25 Jul 2015
Comments0
Perrigo has entered into an agreement to acquire Naturwohl Pharma and its leading German dietary supplement brand, Yokebe. “Our acquisition of the... Read More
Lupin acquire speciality product portfolio of Germany’s Temmler Pharma
Mumbai-based drug maker Lupin Ltd has entered into an asset purchase agreement with German company Temmler Pharma GMBH and CO. KG to... Read More
Lupin to acquire Gavis Pharma for for $880 mn
Lupin, India based pharmaceutical company, will acquire Gavis Pharmaceuticals for Rs 5,610 crore (for $880 mn). Why this acquisition? The acquisition will... Read More